← Back
$VNDA All transactions

Vanda Pharmaceuticals Inc.

A

$ Value

$0

Shares

525,000

Price

$0

Filed

Feb 19

Insider

Name

Polymeropoulos Mihael Hristos

Title

President and CEO

CIK

0001355537

Roles

Director Officer Other

Transaction Details

Transaction Date

2026-02-18

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

2,860,731

Footnotes

Represents shares of common stock underlying a time-based restricted stock unit award ("RSU"). The RSU vests in four (4) equal annual installments with the first annual vest taking place on March 1, 2027, provided the Reporting Person remains continuously employed by the Issuer through each annual vesting date. Vested shares will be delivered on the First Permissible Trading Day (as defined in the RSU Agreement) that occurs on or after the day when the RSUs vest.

Filing Info

Accession No.

0001193125-26-059770

Form Type

4

Issuer CIK

0001347178

Polymeropoulos Mihael Hristos's History

Date Ticker Type Value
2026-03-02 VNDA $1.3M
2026-02-18 VNDA A $0
2025-08-07 VNDA $42K
2025-05-21 VNDA $42K
2025-05-21 VNDA $2K
2025-05-16 VNDA $84K

Other Insiders at VNDA (90d)

Insider Bought Sold Last
Polymeropoulos Mihael Hristos
President and CEO
$1.3M 2026-03-02
Birznieks Gunther
SVP, Business Development
$351K 2026-03-02
Williams Timothy
SVP & General Counsel
$351K 2026-03-02
Wijkstrom Joakim
SVP, Chief Marketing Officer
$255K 2026-03-02
Moran Kevin Patrick
SVP, CFO & Treasurer
$351K 2026-03-02
Honore Tage $241K 2026-02-23